| COMPANY |
Organon & Co. |
| COURT |
United States District Court for the District of New Jersey |
| CASE NUMBER |
2:25-cv-05322 |
| JUDGE |
The Hon. Julien Xavier Neals |
| CLASS PERIOD |
November 3, 2022 through April 30, 2025 |
| SECURITY TYPE |
Securities |
LEAD PLAINTIFF DEADLINE IS JULY 22, 2025.
If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.
Case Background:
Class action lawsuits have been filed on behalf of those who purchased or otherwise acquired Organon & Co. (“Organon”) (NYSE: OGN) publicly traded securities between November 3, 2022, and April 30, 2025 , inclusive (the “Class Period”).
The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Organon faced a higher risk of loss of exclusivity and price erosion as to Nexplanon than implied by its Class Period statements; (2) as a result, Organon’s long-term Nexplanon sales growth was not as strong as Defendants’ portended during the Class Period, and would not reach $1 billion by the end of fiscal year 2025 (much less upwards of $1.5 billion after that), and that Organon was likely not on track to achieve the $1 billion milestone payment from Merck & Co. on its Nexplanon sales thereafter; (3) thus, Organon was not on track to achieve, much less maintain, the $1 billion in free cash flow required to sustain its outsized dividend; (4) consequently, Organon was also not on track to maintain 4.0x debt leverage; (5) as such, Organon might not be able to maintain its corporate debt ratings at their then-current Class Period levels; and (6) as a result, Organon lacked a reasonable basis to report its Class Period business metrics and financial projections.
What is a Lead Plaintiff?
A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.